Enliven (Consulting Services (B2B)) Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
Enliven (Consulting Services (B2B)) General Information
Description
Provider of beverage consulting services intended to negotiate deals between hospitals, airports, restaurants, and other large property owners with beverage brands. The company's services include negotiation and management of exclusive pouring rights contracts and beverage deals of servicing entities with major beverage companies, enabling clients to negotiate contracts regarding the various beverages bought, sold, and distributed at their places of business, improve their revenue and savings.
Contact Information
Website
www.enlivenllc.comCorporate Office
- 4322 Harding Pike
- Suite 417-19
- Nashville, TN 37205
- United States
Corporate Office
- 4322 Harding Pike
- Suite 417-19
- Nashville, TN 37205
- United States
Enliven (Consulting Services (B2B)) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Mar-2014 | Completed | Startup | |||
| 1. Early Stage VC | 01-Sep-2005 | Completed | Startup |
Enliven (Consulting Services (B2B)) Patents
Enliven (Consulting Services (B2B)) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026198053-A1 | Fused tetracyclic quinazoline derivative for use in the treatment of central nervous system (cns) metastasis | Pending | 18-Mar-2025 | ||
| WO-2026151942-A1 | Compounds for inhibition of thyroid stimulating hormone receptor | Pending | 10-Jan-2025 | ||
| WO-2026084950-A1 | 5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases for use in the treatment of cancer | Pending | 16-Oct-2024 | ||
| WO-2026084735-A1 | Formulations of bcr-abl tyrosine kinase inhibitor | Pending | 16-Oct-2024 | ||
| WO-2026030578-A1 | Compounds for inhibition of thyroid stimulating hormone receptor | Pending | 01-Aug-2024 | C07D215/38 |
Enliven (Consulting Services (B2B)) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Enliven (Consulting Services (B2B)) FAQs
-
When was Enliven (Consulting Services (B2B)) founded?
Enliven (Consulting Services (B2B)) was founded in 2005.
-
Where is Enliven (Consulting Services (B2B)) headquartered?
Enliven (Consulting Services (B2B)) is headquartered in Nashville, TN.
-
What is the size of Enliven (Consulting Services (B2B))?
Enliven (Consulting Services (B2B)) has 12 total employees.
-
What industry is Enliven (Consulting Services (B2B)) in?
Enliven (Consulting Services (B2B))’s primary industry is Consulting Services (B2B).
-
Is Enliven (Consulting Services (B2B)) a private or public company?
Enliven (Consulting Services (B2B)) is a Private company.
-
What is Enliven (Consulting Services (B2B))’s current revenue?
The current revenue for Enliven (Consulting Services (B2B)) is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
